Resectr boston scientific
WebMay 1, 2024 · Patent number: 10420956. Abstract: A medicament delivery vehicle, the vehicle comprising a reversibly deformable carrier (RDC) adapted to support the medicament on an outside surface of the carrier, an inside surface of the carrier, or homogeneously dispersed throughout the carrier. Specifically, the medicament delivery … WebNov 17, 2016 · Under the terms of the agreement, Boston Scientific will acquire the Resectr device and other products in Distal Access’ gynecology and urology portfolio. The …
Resectr boston scientific
Did you know?
WebNov 15, 2016 · On November 15, 2016, Boston Scientific acquired medical products company Distal Access - Resectr Tissue Resection Device from Distal Acces Acquisition Highlights. This is Boston Scientific’s 26th transaction in the Medical Products sector. This is Boston Scientific’s 32nd transaction in the United States. WebSPINR, Resectr, PILOT, Shavr, and Maceratr platforms are protected by patents; and other issued & pending patents in the United ... Boston Scientific, Black & Decker, and start-ups. Shawn has a Bachelor’s Degree from the University of Illinois in Champaign, Illinois; a Master’s Degree from Harvard University in Cambridge ...
WebNov 15, 2016 · Boston Scientific has acquired the gynecology and urology portfolio of Distal Access which includes the Resectr, a tissue resection device designed to effectively remove uterine polyps. The device is used in conjunction with a diagnostic hysteroscope. Specific terms of the transaction were not disclosed. — Cynthia Jessup WebBoston Scientific Oct 2016 - May 2024 1 year 8 months. Greater Milwaukee Area Partner ... -ResectR Tissue Resection Territory Business Manager II Zoetis Inc. ...
WebNov 15, 2016 · MARLBOROUGH, Mass., Nov. 15, 2016 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a … WebBOSTON SCIENTIFIC: M0065907041. Quantity Available:0. Tissue Resection Device, 3 mm OD, 7.5 mm Window, 35 cm Cannula Size ... Compatible with your existing gynaecologic surgery instrumentation, Resectr is a versatile and cost-effective polypectomy tool for a variety of surgical settings. See how resectr gives you control without added ...
WebApr 29, 2024 · On April 29, 2024 , Boston Scientific Corporation issued a press release announcing financial results for the first quarter ended March 31, 2024 . ... Symphion™ Tissue Removal System, the Resectr™ Tissue Resection Device and the Genesys HTA™ System -- to Minerva
WebApr 3, 2024 · MARLBOROUGH, Mass., April 3, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2024 on Wednesday, April 26, 2024 at 8:00 a.m. EDT.The call will be hosted by Mike Mahoney, chairman and chief executive … parkland hall prince albertWebFeb 14, 2024 · By Kristin Broughton. Feb. 14, 2024 5:30 am ET. Text. Listen to article. (2 minutes) Medical device maker Boston Scientific Corp. has been buying more companies in recent years through its venture ... parkland hatcher station health centerWebResectr Tissue Resection Device: Classification: Hysteroscope (and Accessories) Applicant: Boston Scientific Corporation 100 Boston Scientific Way Marlborough, MA 01752 : Contact: Brooke Cuddy: Correspondent: Brooke Cuddy Boston Scientific Corporation 100 Boston Scientific Way Marlborough, MA 01752 : Product Code: HIH : CFR Regulation Number ... parkland hamilton terminalWebNov 15, 2016 · Distal Access designs and develops medical devices to enhance patient care including guidewire controllers, catheter controllers, thrombus macerators, and several … parkland gynecology clinicWebResectr is an oscillating resection device that removes multiple endometrial polyps with one entry into the uterus to reduce Abnormal Uterine Bleeding. Precision Medical’s suction instruments improve aspiration and hysteroscopic visualization when performing tissue resection. Streamline and accelerate the diagnosis and treatment of polyps. tim hortons west islandWebMay 11, 2024 · Boston Scientific has been witnessing a positive estimate revision trend for 2024. Over the past 60 days, the Zacks Consensus Estimate for its earnings has moved 6.1% north to $1.57. The Zacks ... parkland gynecologistWebResectr ™ Tissue Resection Device Boston Scientific Traditional 510(k) 510(k) Summary for Resectr ™ Tissue Resection Device – K191538 . A. Sponsor . Boston Scientific … parkland harry hines